Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells

Bone Marrow Transplantation

Volumn 24, Issue 1, 1999, Pages 25-28

  Krieger, M S ^a,i   Schiller, G ^b   Berenson, J R ^b   Stewart, K ^c   Noga, S J ^d   Ballester, O ^e   Tarantolo, S ^f   Stiff, P ^g   Kuhn, D ^a   Scherzo, E ^a   Sing, A ^a   Jacobs, C ^a   White, J M ^a   DiPersio, J ^h  

^a Cell Pro Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Midwestern Regional Medical Center   (United States)

^f UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^g LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ Poniard Pharmaceuticals Inc   (United States)

Author keywords

CD34 selection; CD34+ cell; CEPRATE SC; PBSC

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

EID: 0032808023     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701817     Document Type: Article

References (17)

1. Gianni AL, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoietic stem cells for autotransplantation. Lancet 1989; 9: 580-585.
2. Kessinger A, Armitage JO, Smith DM et al. High dose therapy and autologous peripheral blood stem cells transplantation for patients with lymphoma. Blood 1989; 74: 1260-1265.
3. Martinez E, Sureda A, De Dalmases C et al. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma. Bone Marrow Transplant 1996; 18: 1-7.
4. Alegre A, Tomas JF, Martinex-Chamorro C et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplant 1997; 20: 211-217.
5. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cells transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
6. Demirer T, Buckner CD, Bensinger WI. Optimization of peripheral blood stem cell mobilization. Stem Cells 1996; 14: 106-116.
7. Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
8. 8/kg is sufficient to predict early multilineage engraftment in patients undergoing high dose therapy and transplantation with cryopreserved peripheral blood progenitor cells for malignant lymphoma. Blood 1994; 84: (Suppl. 1): 364 a.
9. Elias AD, Ayash L, Anderson KC et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-3044.
10. Elliot C, Samson DM, Armitage S. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34 positive cell yield by preceding day CD34 positive concentration in peripheral blood. J Clin Oncol 1996; 14: 970-973.
11. + cells after stem cell mobilization predict stem cell yield and post-transplant hematopoietic recovery. J Hematother 1997; 6: 13-19.
12. + cell counts to guide timing and yield of large-scale collection by leukapheresis. J Hematother 1998; 7: 45-52.
13. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
14. + cell purification: experience of 71 immunoaffinity column procedures. Bone Marrow Transplant 1997; 20: 157-162.
15. Jones HM, Jones SA, Watts MJ et al. Development of a simplified single-apheresis approach for peripheral blood progenitor-cells transplantation in previously treated patients with lymphoma. J Clin Oncol 1994; 12: 1693-1702.
16. Ho AD, Gluck S, Germond C. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993; 7: 1738-1746.
17. Jagannath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.